Tata Group ties up with SCTIMST for commercial production of COVID-19 testing kits


2020-06-02 18:04:23

Credit: pixabay.com

Credit: pixabay.com

The Tata Group has entered into a partnership agreement with the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), an institute of national importance, for commercial production of COVID-19 testing kits. The kits will be based on the futuristic RT-LAMP (Reverse Transcriptase of India Loop-Mediated Amplification) technology, which can produce results in significantly less time, thereby increasing the throughput of labs in India, a Tata Sons press release said.

Tata Sons’ tie-up with SCTIMST follows its partnership with the CSIR-Institute of Genomics and Integrative Biology to produce CRISPR-based COVID test kits. These two partnerships will significantly boost Tata Sons’ efforts to cater to the burgeoning demand for COVID testing across the country.